Univo Pharmaceuticals

It was just three years ago that a broad swath of Israeli society, including former prime ministers, defense bigwigs and celebrities seemed to be enamored by the country's up-and-coming cannabis industry.  Former Prime Minister Ehud Barak was...

Famed cannabis breeding and lifestyle company DNA Genetics has partnered up with Israel-based medical cannabis company UNIVO Pharmaceuticals (TLV: UNVO) to bring its products to the Israeli medical cannabis market. The plan is to bring DNA Genetics’ vast catalogue of high-quality strains to...

Israeli medical cannabis company Univo Pharmaceuticals Ltd. (TLV: UNVO) has agreed to a U.K. distribution deal. As part of the agreement, Univo will see up to five tons of its cannabis-based products distributed across the U.K. each year. Unico is chaired by Dr. Chaim Hurvitz, a...

Israeli cannabis company Univo Pharmaceuticals Ltd (TLV: UNVO) saw its stock soar this week, especially on Thursday, after the company reported preliminary results for the first half of 2020. The spike comes on the heels of several company announcements. Univo said it expects to report a gross...

Univo Pharmaceuticals (TASE: UNVO) will provide medical grade cannabis and cannabis-based products, as well as funding, to the RAMBAM medical center in Haifa, Israel. The center will be conducting a study aimed at the development of medical cannabis-based products, including anti-inflammatory...

Medical cannabis company UNIVO Pharmaceuticals (TASE: UNVO) said Sunday it has entered into an exclusive agreement with Canopy Growth Corp (NYSE: CGC) to import, manufacture, advertise and export GMP medical cannabis products in Israel. The deal marks Canopy's entrance into the Israel...

Can-Fite BioPharma Ltd. (NYSE American: said Thursday that new pre-clinical data results related to its collaboration with Univo Pharmaceuticals (TASE:UNVO) show “CBD’s robust anti-neoplastic effect in pre-clinical studies against liver cancer.” The research was conducted on...

Israeli biotechnology company Can-Fite BioPharma Ltd. (NYSE: CANF) said Monday that its drug candidate Piclidenoson for the treatment of osteoarthritis in mammals has been granted Patent No. 10,265,337 from the U.S. Patent and Trademark Office with the title “Use of A3 Adenosine Receptor...

Biotechnology company Can-Fite BioPharma Ltd. (NYSE: CANF) announced Tuesday it has partnered with the medical cannabis company Univo Pharmaceuticals to work on developing cannabinoid-based pharmaceuticals for treating cancer, autoimmune, metabolic and inflammatory diseases. The...